Literature DB >> 19765515

Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter?

Lynn G Stansbury1, Richard P Dutton, Deborah M Stein, Grant V Bochicchio, Thomas M Scalea, John R Hess.   

Abstract

Since a report in October 2007 of dramatic improvements in trauma mortality in a military population when massive transfusion of red blood cells (RBC) was accompanied by plasma replacement at 1:1 proportions, interest in the plasma-to-RBC ratio during resuscitation in both the trauma and transfusion communities has been intense. Over the 7-month period from August 2008 through February 2009, a further 9 major studies examining experience with plasma replacement in massively transfused civilian trauma patients have been published. This flood of observational studies is likely to continue. In this review, the authors examine the findings of these initial studies, highlighting the epidemiologic and analytic methodologies used, and the likely influence of these methodologies on the reported outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765515     DOI: 10.1016/j.tmrv.2009.06.002

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  14 in total

1.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

2.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

3.  Balanced ratio of plasma to packed red blood cells improves outcomes in massive transfusion: A large multicenter study.

Authors:  Jiang-Cun Yang; Cui-Xiang Xu; Yang Sun; Qian-Li Dang; Ling Li; Yong-Gang Xu; Yao-Jun Song; Hong Yan
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

4.  Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.

Authors:  Deborah J Novak; Yu Bai; Rhonda K Cooke; Marisa B Marques; Magali J Fontaine; Jerome L Gottschall; Patricia M Carey; Richard M Scanlan; Eberhard W Fiebig; Ira A Shulman; Janice M Nelson; Sherri Flax; Veda Duncan; Jennifer A Daniel-Johnson; Jeannie L Callum; John B Holcomb; Erin E Fox; Sarah Baraniuk; Barbara C Tilley; Martin A Schreiber; Kenji Inaba; Sandro Rizoli; Jeanette M Podbielski; Bryan A Cotton; John R Hess
Journal:  Transfusion       Date:  2015-03-30       Impact factor: 3.157

Review 5.  Massive transfusion protocols for patients with substantial hemorrhage.

Authors:  Pampee P Young; Bryan A Cotton; Lawrence T Goodnough
Journal:  Transfus Med Rev       Date:  2011-06-12

6.  Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma (CME).

Authors:  Andreas R de Biasi; Lynn G Stansbury; Richard P Dutton; Deborah M Stein; Thomas M Scalea; John R Hess
Journal:  Transfusion       Date:  2011-02-18       Impact factor: 3.157

Review 7.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

8.  Fixed volume or fixed pressure: a murine model of hemorrhagic shock.

Authors:  Lauryn K Kohut; Sophie S Darwiche; John M Brumfield; Alicia M Frank; Timothy R Billiar
Journal:  J Vis Exp       Date:  2011-06-06       Impact factor: 1.355

Review 9.  The acute management of trauma hemorrhage: a systematic review of randomized controlled trials.

Authors:  Nicola Curry; Sally Hopewell; Carolyn Dorée; Chris Hyde; Karim Brohi; Simon Stanworth
Journal:  Crit Care       Date:  2011-03-09       Impact factor: 9.097

10.  A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.

Authors:  Simon J Stanworth; Timothy S Walsh; Robin J Prescott; Robert J Lee; Douglas M Watson; Duncan Wyncoll
Journal:  Crit Care       Date:  2011-04-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.